| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/22/2014 | US8784890 Methods for producing ECM-based biomaterials |
| 07/22/2014 | US8784884 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency |
| 07/22/2014 | US8784875 Collagen for use in the treatment of skin diseases |
| 07/22/2014 | US8784840 Method for screening modulators of apoptosis |
| 07/22/2014 | US8784837 Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule |
| 07/22/2014 | US8784834 Recombinant fusion interferon for animals |
| 07/22/2014 | US8784833 Prenatal enzyme replacement therapy for hypophosphatasia |
| 07/22/2014 | US8784829 Lawsonia intracellularis vaccines |
| 07/22/2014 | US8784825 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC |
| 07/22/2014 | US8784822 Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis |
| 07/22/2014 | US8784821 Human-anti-human cd3 binding molecules |
| 07/22/2014 | US8784814 Method for inhibiting binding to B-cell receptor |
| 07/22/2014 | US8784809 Vascular endothelial growth factor 2 |
| 07/22/2014 | US8784805 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 07/22/2014 | US8784804 Nutraceutical composition that comprises extract of andean shilajit, for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral aging |
| 07/22/2014 | US8784799 Duplexed parvovirus vectors |
| 07/22/2014 | US8784797 Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma |
| 07/22/2014 | US8784796 Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients |
| 07/22/2014 | US8784795 Methods for determining personalized treatment compositions for prostate cancer and breast cancer |
| 07/22/2014 | US8784777 Flexibly labeling peptides |
| 07/22/2014 | US8784773 Hydrogel nanocomposite wound dressing and a method of synthesizing the same |
| 07/22/2014 | CA2778826C Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
| 07/22/2014 | CA2652219C Macrocyclic compounds as antiviral agents |
| 07/22/2014 | CA2621262C Thio-containing inhibitors of aminopeptidase p, compositions thereof and method of use |
| 07/22/2014 | CA2584489C Kaspp (lrrke) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 07/22/2014 | CA2573144C Methods for treating conditions associated with masp-2 dependent complement activation |
| 07/22/2014 | CA2570324C Rage fusion proteins and methods of use |
| 07/22/2014 | CA2560906C Method for modification of nmda receptors through inhibition of src |
| 07/22/2014 | CA2537158C Cxcr4 antagonist and use thereof |
| 07/22/2014 | CA2533423C Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 07/22/2014 | CA2441809C Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses |
| 07/22/2014 | CA2412845C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 07/22/2014 | CA2405299C Method of treatment using ligand-immunogen conjugates |
| 07/22/2014 | CA2388562C Mammalian cytokines; related reagents and methods |
| 07/22/2014 | CA2383774C Fibroblast growth factor-like polypeptides |
| 07/22/2014 | CA2383636C Collagen membrane for mucosa regeneration |
| 07/22/2014 | CA2376506C Neuromedin b and somatostatin receptor agonists |
| 07/17/2014 | WO2014110503A1 Methods and compositions for treating cancer |
| 07/17/2014 | WO2014110451A1 Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders |
| 07/17/2014 | WO2014110420A1 Peptidomimetic compounds |
| 07/17/2014 | WO2014110399A1 Method for increasing muscle growth by blocking sirtuin activity |
| 07/17/2014 | WO2014110353A1 Notch ligand bound bicompatible substrates and their use in bone formation |
| 07/17/2014 | WO2014110090A1 Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems |
| 07/17/2014 | WO2014108549A1 Methods and pharmaceutical compositions for the cardioprotection |
| 07/17/2014 | WO2014108547A1 A peptide conjugate suitable for use as an anti-cancer agent |
| 07/17/2014 | WO2014108530A1 Modified ace2 polypeptides |
| 07/17/2014 | WO2014108475A1 Peptides for the treatment of cancer |
| 07/17/2014 | WO2014108469A1 Polymyxins, compositions, methods of making and methods of use |
| 07/17/2014 | WO2014108330A1 High-affinity matriptase inhibitors |
| 07/17/2014 | WO2014081980A3 Mutant ngal proteins and uses thereof |
| 07/17/2014 | WO2014081944A3 Egfr and c-met-fibronectin type iii domain binding molecules |
| 07/17/2014 | WO2014081702A3 Synthetic linear apelin mimetics for the treatment of heart failure |
| 07/17/2014 | WO2014078082A3 Cross-linked collagen comprising an antifungal agent |
| 07/17/2014 | WO2014062587A3 Injectable cancer compositions |
| 07/17/2014 | WO2013182905A3 Mechanism, diagnostic, and treatments for complications of renal failure |
| 07/17/2014 | WO2013179264A3 Compounds modulating astrocytic release of substances through connexins and pannexins and treatment of psychiatric disorders |
| 07/17/2014 | WO2013090833A8 Angiotensins for treatment of fibrosis |
| 07/17/2014 | US20140200547 Method for Altering Drug Pharmacokinetics Based on Medical Delivery Platform |
| 07/17/2014 | US20140200531 Mixture for transdermal delivery of low and high molecular weight compounds |
| 07/17/2014 | US20140200516 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 07/17/2014 | US20140200332 Low dose methods for treating disorders in which tnf-alpha activity is detrimental |
| 07/17/2014 | US20140200226 Anti-malarial compounds from marine natural products |
| 07/17/2014 | US20140200185 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 07/17/2014 | US20140200184 Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
| 07/17/2014 | US20140200183 Treatment of cardiac arrhythmias |
| 07/17/2014 | US20140200182 Methods of administering bone morphogenetic protein compositions |
| 07/17/2014 | US20140200181 System and method of modeling erythropoiesis and its management |
| 07/17/2014 | US20140200176 Nutritional compositions containing magnesium threonate and uses thereof |
| 07/17/2014 | US20140200175 Suppression of toxin production of clostridium difficle |
| 07/17/2014 | US20140200174 Peptide bfp4 for promoting osteogenesis or vascularization and use thereof |
| 07/17/2014 | US20140199762 Immunotherapeutic Methods Using Epitopes of WT-1 and GATA-1 |
| 07/17/2014 | US20140199414 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 07/17/2014 | US20140199411 Therapeutic agent for emphysema and copd |
| 07/17/2014 | US20140199408 Therapeutic stem cell nutrient composition and uses thereof |
| 07/17/2014 | US20140199398 High capacity diektopiperazine microparticles and methods |
| 07/17/2014 | US20140199377 Multiple growth factor compositions, methods of fabrication, and methods of treatment |
| 07/17/2014 | US20140199347 Adjuvant compositions with 4-1bbl |
| 07/17/2014 | US20140199332 Method of treating cancer with an hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/17/2014 | US20140199329 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| 07/17/2014 | US20140199322 Transdiscal Administration of Specific Inhibitors of Pro-Inflammatory Cytokines |
| 07/17/2014 | US20140199320 Modulators of the nlrp3 inflammasome il-1beta pathway for the prevention and treatment of acne |
| 07/17/2014 | US20140199313 Process for the Production of Fine Chemicals |
| 07/17/2014 | US20140199303 Stable Liquid Formulation of Etanercept |
| 07/17/2014 | US20140199291 Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml) |
| 07/17/2014 | US20140199289 Use of matrix metalloproteinase inhibitors to treat tuberculosis |
| 07/17/2014 | US20140199288 Pharmaceutical compositions containing botulinum neurotoxin |
| 07/17/2014 | US20140199287 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 07/17/2014 | US20140199286 Lyophilization process |
| 07/17/2014 | US20140199285 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 07/17/2014 | US20140199282 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/17/2014 | US20140199260 Compositions and methods for the treatment of hiv |
| 07/17/2014 | US20140199259 Stabilized liquid formulation |
| 07/17/2014 | US20140199236 Androgen receptor modulator and uses thereof |
| 07/17/2014 | US20140199232 Targeted Therapeutic Nanoparticles |
| 07/16/2014 | EP2754718A1 Vascular endothelial myostatin mutant that mutates at atp binding sites |
| 07/16/2014 | EP2754666A1 Peptide secreted by lactobacillus plantarum with immunomodulating function |
| 07/16/2014 | EP2754665A1 Peptide inhibiting matrix metalloproteanases activity and use thereof |
| 07/16/2014 | EP2754453A1 Conjugate of a cationic antimicrobial peptide and of a fatty acid for use as an anti-cancer agent |
| 07/16/2014 | EP2754451A1 The use of ache as nuclease |
| 07/16/2014 | EP2754450A1 Lactoferricin derived peptides |